Perhaps because it was because the company already had a significant drug in the market with some sales history and growth prospects, that the company was already fairly valued?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.01 |
Change
0.050(0.39%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $1.707M | 132.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 240 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 175 | 2 |
View Market Depth
| Last trade - 12.09pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |